Clinical trial
Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer (STIRR Cervix Study)
NCT06804135 is registered in ClinicalTrials.gov with Tata Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer (STIRR Cervix Study)
- Lead sponsor
- Tata Memorial Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 25, 2025
- Completion date
- January 30, 2030
- Enrollment
- 110 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervical carcinoma